We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoparticle Breakthrough Leads to Highly Accurate Pregnancy Tests

By LabMedica International staff writers
Posted on 07 Nov 2011
Extremely accurate pregnancy tests could be created by precisely measuring specific nanoparticle cluster-size agglomeration and the resulting characteristic light absorption.

Researchers at the US National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA) developed the new technique by coating gold nanoparticles with antibodies to human chorionic gonadotropin (hCG), a hormone produced by an embryo following conception. More...
The researchers first prepared samples of gold nanoparticles with a controlled distribution of sizes; they were then allowed to agglomerate in gradually growing clusters. The clumping process was then deactivated after varying lengths of time by adding a stabilizing agent, preventing further agglomeration.

Since only certain size clusters are optimal for this technique, analytical ultracentrifugation (AUC) was used to simultaneously sort the clusters by size and measure their light absorption. AUC causes the nanoparticle clusters to separate by size, the smaller, lighter clusters moving more slowly than the larger ones. While this is happening, the sample containers are repeatedly scanned with light and the amount of light passing through the sample for each color frequency is recorded; the larger the cluster, the more light is absorbed by lower frequencies. Measuring the absorption by frequency across the sample containers allowed the researchers both to watch the gradual separation of cluster sizes and to correlate absorbed frequencies with specific cluster sizes. The study was published on September 3, 2011, in ACS Nano.

“Most previous measurements of absorption spectra for solutions of nanoparticles were able only to measure the bulk spectra - the absorption of all the different cluster sizes mixed together,” said lead author biomedical engineer Justin Zook, PhD, of the NIST. “AUC makes it possible to measure the quantity and distribution of each nanoparticle cluster without being confounded by other components in complex biological mixtures, such as proteins.”

Related Links:
US National Institute of Standards and Technology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Immunoassay Analyzer
Procise DX
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.